☆ 4.6 Review

Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases

EXPERT OPINION ON DRUG DELIVERY (2023)

Related references

Note: Only part of the references are listed.
Review Biotechnology & Applied Microbiology

Biologic therapies for chronic obstructive pulmonary disease

Maria Gabriella Matera et al.

Summary: No mAb directed against cytokines or chemokines has shown therapeutic impact in COPD patients, except for mAbs targeting the IL-5 pathway which have a weak effect in patients with eosinophilic COPD. This reflects the complexity of COPD where no single cytokine or chemokine plays a dominant role. Therefore, mAbs targeting specific cytokines or chemokines should be evaluated in limited and focused populations.

EXPERT OPINION ON BIOLOGICAL THERAPY (2023)

Add to Collection
Article Medicine, Research & Experimental

Solid-State NMR Characterization of Lyophilized Formulations of Monoclonal Antibody Therapeutics

Jacqueline Perodeau et al.

Summary: Monoclonal antibodies (mAbs) are an important and growing class of biotherapeutic drugs. Solution-state nuclear magnetic resonance (NMR) spectroscopy provides reliable and high-resolution characterization of the higher-order structure (HOS) of mAbs in aqueous-based preparations. However, techniques for the solid-state characterization of HOS in solid mAb preparations are limited. This study proposes the use of solid-state NMR (ssNMR) fingerprinting to directly inform on the HOS of solid-phase mAb preparations.

MOLECULAR PHARMACEUTICS (2023)

Add to Collection
Review Pharmacology & Pharmacy

Inhalable neutralizing antibodies - promising approach to combating respiratory viral infections

Michael Y. T. Chow et al.

Summary: Monoclonal antibodies are an exciting therapeutic option for respiratory viral infections. However, their delivery to the airways is challenging due to the limitations of conventional parenteral administration. Inhaled therapy and advancements in antibody engineering offer potential solutions to enhance the efficacy and safety of neutralizing antibodies against respiratory viral infections.

TRENDS IN PHARMACOLOGICAL SCIENCES (2023)

Add to Collection
Article Respiratory System

Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma

Gail M. Gauvreau et al.

Summary: The study evaluated the efficacy and safety of ecleralimab, an inhaled neutralizing antibody fragment against TSLP, in subjects with mild atopic asthma. The results showed that ecleralimab significantly reduced allergen-induced bronchoconstriction and airway inflammation, and it was safe in subjects with mild atopic asthma.

EUROPEAN RESPIRATORY JOURNAL (2023)

Add to Collection
Article Biotechnology & Applied Microbiology

Recently approved and emerging monoclonal antibody immune checkpoint inhibitors for the treatment of advanced non-small cell lung cancer

Danilo Rocco et al.

Summary: CTLA-4/PD-1/PD-L1-directed immune checkpoint inhibitors are standard therapies for advanced non-small cell lung cancer, but new monoclonal antibody therapies are emerging as promising treatments for this condition.

EXPERT OPINION ON BIOLOGICAL THERAPY (2023)

Add to Collection
Review Pharmacology & Pharmacy

Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPD

Rossella Laitano et al.

Summary: This article evaluates the potential role of delivering monoclonal antibodies (mAbs) via inhalation in the treatment of asthma and chronic obstructive pulmonary disease (COPD) through a systematic review of randomized control trials (RCTs). Compared to systemic administration, delivering mAbs via inhalation offers faster onset of action, greater efficacy at lower doses, minimal systemic exposure, and lower risk of adverse events. However, the delivery of mAbs via inhalation remains challenging and controversial, and further well-designed RCTs are needed to assess their potential role in asthma and COPD treatment.

EXPERT OPINION ON DRUG DELIVERY (2023)

Add to Collection
Article Pharmacology & Pharmacy

A multiplex inhalation platform to model in situ like aerosol delivery in a breathing lung-on-chip

Arunima Sengupta et al.

Summary: Prolonged exposure to environmental respirable toxicants can lead to the development and worsening of severe respiratory diseases. In order to better predict the toxicity of inhaled particles, alternative in vitro human-relevant models are being used. The Cloud a AX12 model, consisting of a cloud-based exposure chamber (VITROCELL) and a lung-on-chip system (AlveoliX), provides a mechanistic approach for studying inhalation toxicity risks. This state-of-the-art pre-clinical tool allows for the study of air-liquid interface and cyclic stretch culture conditions on the air-blood barrier sensitivity, cytotoxicity, and inflammation.

FRONTIERS IN PHARMACOLOGY (2023)

Add to Collection
Review Immunology

A four-part guide to lung immunology: Invasion, inflammation, immunity, and intervention

Indiwari Gopallawa et al.

Summary: Lungs are vital organs involved in gas exchange and are directly affected by allergens, inflammatory mediators, and pathogens. The immune system in the lungs plays a crucial role in maintaining immune homeostasis. Imbalances and dysregulations in the immune responses can lead to inflammatory and autoimmune diseases. This review focuses on the immunology of the lungs, advancements in therapies, and the impact of inhalation devices in managing lung diseases.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection
Review Immunology

Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy

Susanna Esposito et al.

Summary: Monoclonal antibodies (mABs) are effective and safe proteins produced in the laboratory that target specific epitopes of viruses or bacterial pathogens. In this paper, the characteristics of licensed and advanced-stage developed mABs for prophylaxis and therapy of infectious diseases are discussed. While mABs have shown efficacy in treating infections, their greater effectiveness lies in prevention and early post-exposure treatment. In the absence of vaccines for many infectious diseases, mABs can be an attractive option, especially in emergency situations and when facing multidrug-resistant strains.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection
Review Pharmacology & Pharmacy

Imaging drug delivery to the lungs: Methods and applications in oncology

Francis Man et al.

Summary: Direct delivery of drugs to the lungs through inhalation is a logical approach to treat lung cancer, but despite significant efforts, this strategy has not made progress in clinical trials. Imaging drug delivery is a useful tool to understand and develop new strategies for drug delivery. This review focuses on imaging studies of inhalation drug delivery, providing an overview of the field, discussing challenges and barriers, and exploring different imaging modalities and their applications in oncology.

ADVANCED DRUG DELIVERY REVIEWS (2023)

Add to Collection
Review Oncology

Monoclonal antibodies for the treatment of squamous cell carcinoma: A literature review

Amirhossein Tamimi et al.

Summary: Squamous cell carcinoma (SCC) is a common and heterogenous malignancy, and the management of advanced cases remains challenging. Monoclonal antibodies (Mabs) have shown significant efficacy and acceptable safety in treating SCC. AntiEGFR Mabs and checkpoint inhibitors are highly potent options in SCC therapy.

CANCER REPORTS (2023)

Add to Collection
Review Pharmacology & Pharmacy

Strategies to Overcome Biological Barriers Associated with Pulmonary Drug Delivery

Adam J. Plaunt et al.

Summary: While inhalation route has been used for pharmacologic effect, it posed challenges for treating lung disease until sophisticated device and formulation technologies emerged. Now, there are several inhalation device technologies that efficiently deliver therapeutics to the lung and avoid excessive deposition elsewhere. Formulation technologies and drug chemistry modifications have also emerged to overcome degradation and clearance mechanisms, improve tolerability, or facilitate intracellular uptake.

PHARMACEUTICS (2022)

Add to Collection
Article Chemistry, Medicinal

Identification of Stability Constraints in the Particle Engineering of an Inhaled Monoclonal Antibody Dried Powder

Ashlee D. Brunaugh et al.

Summary: Monoclonal antibody-based therapies have the potential to be a valuable treatment modality for acute and chronic lung diseases. Direct delivery to the lungs via inhalation can provide higher drug concentrations at the site of disease with reduced off-target effects. However, there is limited understanding of the impact of particle engineering processes on the stability and performance of dry powder inhaler formulations of monoclonal antibodies.

JOURNAL OF PHARMACEUTICAL SCIENCES (2022)

Add to Collection
Article Medicine, Research & Experimental

Aggregation of Lactoferrin Caused by Droplet Atomization Process via a Two-Fluid Nozzle: The Detrimental Effect of Air-Water Interfaces

Huy M. Dao et al.

Summary: Biological macromolecules, especially therapeutic proteins, are sensitive to denaturation during the manufacturing of dosage forms. This study compared the effects of droplet formation mechanisms in thin-film freeze-drying (TFFD) and spray freeze-drying (SFD) on protein stability using lactoferrin as a model. It found that the spraying process had a more negative impact on the tertiary structure of proteins, resulting in conformational changes. Additionally, surface-active proteins were more prone to aggregation compared to non-surface-active proteins. The interfacial-induced denaturation during spraying was primarily influenced by the size of atomized droplets.

MOLECULAR PHARMACEUTICS (2022)

Add to Collection
Review Biotechnology & Applied Microbiology

Inhaled antibodies: Quality and performance considerations

Anthony James Hickey et al.

Summary: The use of antibodies in the treatment of lung diseases is increasing, with challenges in formulation and delivery for protein therapeutics. Attention to molecular integrity is crucial during aerosol delivery for pulmonary administration. Drug product development should consider administration route, dosage form, quality, and performance measures for effective delivery matching the needs of the drug and the disease.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

Add to Collection
Article Pharmacology & Pharmacy

Inhaled IgG1 antibodies: The buffering system is an important driver of stability during mesh-nebulization

Alexie Mayor et al.

Summary: In the past decade, oral inhalation has been a popular research topic for direct treatment of respiratory diseases. The formulation of inhaled antibodies plays a crucial role in their stability and lung safety. This study reveals the significant impact of the buffering system on the stability of monoclonal antibodies during nebulization.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2022)

Add to Collection
Review Biotechnology & Applied Microbiology

Anticalin® proteins: from bench to bedside

Friedrich-Christian Deuschle et al.

Summary: Anticalin proteins are engineered versions of lipocalins that form a new class of clinical-stage biopharmaceuticals. Through combinatorial gene libraries and molecular selection techniques, the natural ligand specificities of lipocalins have been expanded from small molecules to peptides and proteins, leading to the development of promising Anticalin lead candidates in various disease areas. Anticalins offer an alternative to antibodies with potentially superior features as next-generation biologics, with examples of drug candidates under preclinical and clinical development.

EXPERT OPINION ON BIOLOGICAL THERAPY (2021)

Add to Collection
Article Pathology

Perspectives on Lung Dose and Inhaled Biomolecules

Ronald K. Wolff

Summary: Dose plays a crucial role in studies of inhaled agents, impacting the understanding of dose delivery to humans and animals, as well as safety implications. Inhalation exposure makes it challenging to determine total delivered dose, with the focus generally on deposition in the alveolar region for biologics.

TOXICOLOGIC PATHOLOGY (2021)

Add to Collection
Review Pharmacology & Pharmacy

Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs

Maria Gabriella Matera et al.

Summary: Inhaled drugs play a crucial role in treating lung pathologies, but difficulties persist in assessing lung concentrations and interpreting their therapeutic action. Understanding the PK/PD relationship is essential for predicting therapeutic effects, but challenges remain due to the complex structure of the lungs and physical interactions with drugs. New methods are improving our understanding of inhaled drugs, but regulatory readiness is still a concern, requiring continued reliance on plasma concentrations as a proxy for lung deposition.

EXPERT OPINION ON DRUG DELIVERY (2021)

Add to Collection
Review Pharmacology & Pharmacy

Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy

Carlos Cruz-Teran et al.

Summary: The article discusses the global efforts to combat the COVID-19 pandemic with potent neutralizing mAbs and highlights the challenges faced by current antiviral mAbs. It also presents evidence supporting inhaled delivery of antiviral mAbs as an early intervention against COVID-19.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Add to Collection
Review Immunology

Diversity of Macrophages in Lung Homeostasis and Diseases

Fei Hou et al.

Summary: Different types of lung macrophages play diverse roles and possess unique characteristics in lung diseases. Understanding the similarities and differences among these macrophages is crucial for the study of lung diseases.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection
Review Biotechnology & Applied Microbiology

Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections

Hilal Ahmad Parray et al.

Summary: The route of administration plays a crucial role in the success of therapeutic agents, with inhalation being a promising strategy for treating respiratory diseases by providing higher concentrations of drugs in the respiratory airways and overcoming the limitations of systemic administration.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)

Add to Collection
Article Pharmacology & Pharmacy

Oral inhalation for delivery of proteins and peptides to the lungs

Eleonore Frohlich et al.

Summary: Oral inhalation is the preferred route for delivering small molecules to the lungs, and could be beneficial for treating lung diseases. Main obstacles for pulmonary delivery of biologics include insufficient stability of proteins and the biological environment of the lung, but novel nebulizers and dry powder formulations can improve delivery.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)

Add to Collection
Review Cell Biology

Alveolar and lung interstitial macrophages: Definitions, functions, and roles in lung fibrosis

Ting Shi et al.

Summary: Lung M phi s are the main innate immune cells in the lung, playing important roles in host defense and immune regulation during homeostasis. Alveolar M phi s (AMs) and interstitial M phi s (IMs) are two subsets of lung M phi s, distinguished by their locations and endowed with distinct features and plasticity based on their origins and immunological microenvironment. This review discusses the latest definitions and functions of lung M phi s at homeostasis and highlights their divergent roles in lung fibrosis.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Add to Collection
Review Chemistry, Medicinal

Physicochemical Stability of Monoclonal Antibodies: A Review

Yoann Le Basle et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Add to Collection
Article Materials Science, Biomaterials

Effect of Shear Stresses on Adenovirus Activity and Aggregation during Atomization To Produce Thermally Stable Vaccines by Spray Drying

Blair A. Morgan et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)

Add to Collection
Article Pharmacology & Pharmacy

Protein stability during nebulization: Mind the collection step!

Elsa Bodier-Montagutelli et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)

Add to Collection
Review Pharmacology & Pharmacy

Pulmonary Delivery of Biological Drugs

Wanling Liang et al.

PHARMACEUTICS (2020)

Add to Collection
Review Biochemistry & Molecular Biology

Developing inhaled protein therapeutics for lung diseases

Abigail A. Matthews et al.

MOLECULAR BIOMEDICINE (2020)

Add to Collection
Review Respiratory System

Severe Asthma and Biological Therapy: When, Which, and for Whom

Paola Rogliani et al.

PULMONARY THERAPY (2020)

Add to Collection
Review Pharmacology & Pharmacy

Improving cellular uptake of therapeutic entities through interaction with components of cell membrane

Renshuai Zhang et al.

DRUG DELIVERY (2019)

Add to Collection
Article Medicine, Research & Experimental

Exploring the fate of inhaled monoclonal antibody in the lung parenchyma by microdialysis

Antoine Guillon et al.

MABS (2019)

Add to Collection
Review Pharmacology & Pharmacy

Insight into pulmonary drug delivery: Mechanism of drug deposition to device characterization and regulatory requirements

Nagarjun Rangaraj et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2019)

Add to Collection
Review Pharmacology & Pharmacy

Strategies to Enhance Drug Absorption via Nasal and Pulmonary Routes

Maliheh Ghadiri et al.

PHARMACEUTICS (2019)

Add to Collection
Review Cardiac & Cardiovascular Systems

Monoclonal antibodies for severe asthma: Pharmacokinetic profiles

Maria Gabriella Matera et al.

RESPIRATORY MEDICINE (2019)

Add to Collection
Editorial Material Immunology

Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!

Thomas Secher et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection
Article Respiratory System

Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates

Cedric Vonarburg et al.

RESPIRATORY RESEARCH (2019)

Add to Collection
Article Critical Care Medicine

Efficacy of an Inhaled Interleukin-13 Antibody Fragment in a Model of Chronic Asthma

Daniel Lightwood et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Add to Collection
Review Respiratory System

Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes

Jens Markus Borghardt et al.

CANADIAN RESPIRATORY JOURNAL (2018)

Add to Collection
Review Pharmacology & Pharmacy

Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies

Nashwa Osman et al.

EXPERT OPINION ON DRUG DELIVERY (2018)

Add to Collection
Editorial Material Pharmacology & Pharmacy

Designing inhaled protein therapeutics for topical lung delivery: what are the next steps?

Elsa Bodier-Montagutelli et al.

EXPERT OPINION ON DRUG DELIVERY (2018)

Add to Collection
Review Pharmacology & Pharmacy

Insights on animal models to investigate inhalation therapy: Relevance for biotherapeutics

A. Guillon et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)

Add to Collection
Article Chemistry, Multidisciplinary

Fate of PEGylated antibody fragments following delivery to the lungs: Influence of delivery site, PEG size and lung inflammation

Harshad P. Patil et al.

JOURNAL OF CONTROLLED RELEASE (2018)

Add to Collection
Review Engineering, Chemical

Complexity in Pharmaceutical Powders for Inhalation: A perspective

Anthony J. Hickey

KONA POWDER AND PARTICLE JOURNAL (2018)

Add to Collection
Article Critical Care Medicine

Aerosol Delivery Devices for Obstructive Lung Diseases

Roy A. Pleasants et al.

RESPIRATORY CARE (2018)

Add to Collection
Article Pharmacology & Pharmacy

Dosing considerations for inhaled biologics

Silvia Ferrati et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)

Add to Collection
Article Medicine, General & Internal

Randomized study of the safety and pharmacodynamics of inhaled interleukin-13 monoclonal antibody fragment VR942

Gary Burgess et al.

EBIOMEDICINE (2018)

Add to Collection
Article Pharmacology & Pharmacy

Mesh nebulizers have become the first choice for new nebulized pharmaceutical drug developments

John N. Pritchard et al.

THERAPEUTIC DELIVERY (2018)

Add to Collection
Article Pharmacology & Pharmacy

A comprehensive screening platform for aerosolizable protein formulations for intranasal and pulmonary drug delivery

Martina Roehm et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)

Add to Collection
Article Pharmacology & Pharmacy

Optimization and characterization of spray-dried IgG formulations: a design of experiment approach

Homa Faghihi et al.

DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2017)

Add to Collection
Review Pharmacology & Pharmacy

Drug delivery to the lungs: challenges and opportunities

Stephen P. Newman

THERAPEUTIC DELIVERY (2017)

Add to Collection
Article Pharmacology & Pharmacy

Inhaled Biologics: From Preclinical to Product Approval

Kristin Fathe et al.

CURRENT PHARMACEUTICAL DESIGN (2016)

Add to Collection
Review Pharmacology & Pharmacy

Nanobodies as therapeutics: big opportunities for small antibodies

Sophie Steeland et al.

DRUG DISCOVERY TODAY (2016)

Add to Collection
Review Pharmacology & Pharmacy

Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease

Maria Gabriella Matera et al.

DRUGS (2016)

Add to Collection
Article Medicine, Research & Experimental

Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31-April 1, 2016, Tours, France

Guillaume Desoubeaux et al.

MABS (2016)

Add to Collection
Article Biochemistry & Molecular Biology

Matched-Comparative Modeling of Normal and Diseased Human Airway Responses Using a Microengineered Breathing Lung Chip

Kambez H. Benam et al.

CELL SYSTEMS (2016)

Add to Collection
Review Pharmacology & Pharmacy

Nebulization as a delivery method for mAbs in respiratory diseases

Renaud Respaud et al.

EXPERT OPINION ON DRUG DELIVERY (2015)

Add to Collection
Review Pharmacology & Pharmacy

Delivery strategies for sustained drug release in the lungs

Cristina Loira-Pastoriza et al.

ADVANCED DRUG DELIVERY REVIEWS (2014)

Add to Collection
Article Chemistry, Multidisciplinary

Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system

L. Guilleminault et al.

JOURNAL OF CONTROLLED RELEASE (2014)

Add to Collection
Article Medicine, Research & Experimental

Effect of formulation on the stability and aerosol performance of a nebulized antibody

Renaud Respaud et al.

MABS (2014)

Add to Collection
Article Critical Care Medicine

Tobramycin Inhalation Powder in Cystic Fibrosis Patients: Response by Age Group

David E. Geller et al.

RESPIRATORY CARE (2014)

Add to Collection
Review Allergy

Omalizumab in Asthma: An Update on Recent Developments

Marc Humbert et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)

Add to Collection
Review Respiratory System

Jet, Ultrasonic, and Mesh Nebulizers: An Evaluation of Nebulizers for Better Clinical Outcomes

Arzu Ari

EURASIAN JOURNAL OF PULMONOLOGY (2014)

Add to Collection
Review Biochemistry & Molecular Biology

Nanobodies: Natural Single-Domain Antibodies

Serge Muyldermans

ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)

Add to Collection
Review Critical Care Medicine

Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges

Christian A. Ruge et al.

LANCET RESPIRATORY MEDICINE (2013)

Add to Collection
Article Biochemistry & Molecular Biology

Nebulized Anti-IL-13 Monoclonal Antibody Fab′ Fragment Reduces Allergen-Induced Asthma

Jonathan Hacha et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)

Add to Collection
Article Respiratory System

Effect of Aging on Cough and Swallowing Reflexes: Implications for Preventing Aspiration Pneumonia

Satoru Ebihara et al.

LUNG (2012)

Add to Collection
Article Multidisciplinary Sciences

The Interplay of Lung Surfactant Proteins and Lipids Assimilates the Macrophage Clearance of Nanoparticles

Christian A. Ruge et al.

PLOS ONE (2012)

Add to Collection
Review Biotechnology & Applied Microbiology

Nanocarriers for pulmonary administration of peptides and therapeutic proteins

Fernanda Andrade et al.

NANOMEDICINE (2011)

Add to Collection
Article Chemistry, Multidisciplinary

The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors

Agnes Maillet et al.

PHARMACEUTICAL RESEARCH (2011)

Add to Collection
Article Allergy

Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in a monkey model of asthma

A. Tomkinson et al.

ALLERGY (2010)

Add to Collection
Article Pharmacology & Pharmacy

Novel pMDI formulations for pulmonary delivery of proteins

Hao-Ying Li et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)

Add to Collection
Review Respiratory System

The Particle has Landed-Characterizing the Fate of Inhaled Pharmaceuticals

John S. Patton et al.

JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2010)

Add to Collection
Article Allergy

Thymic stromal lymphopoietin-induced human asthmatic airway epithelial cell proliferation through an IL-13-dependent pathway

Abdelhabib Semlali et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)

Add to Collection
Article Medicine, Research & Experimental

Antibody fragments Hope and hype

Aaron L. Nelson

MABS (2010)

Add to Collection
Review Biotechnology & Applied Microbiology

The safety and side effects of monoclonal antibodies

Trevor T. Hansel et al.

NATURE REVIEWS DRUG DISCOVERY (2010)

Add to Collection
Article Medicine, Legal

Practical approaches to dose selection for first-in-human clinical trials with novel biopharmaceuticals

Jay Tibbitts et al.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2010)

Add to Collection
Article Multidisciplinary Sciences

Design of therapeutic proteins with enhanced stability

Naresh Chennamsetty et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Add to Collection
Review Chemistry, Multidisciplinary

Pharmaceutical particle engineering via spray drying

Reinhard Vehring

PHARMACEUTICAL RESEARCH (2008)

Add to Collection
Review Chemistry, Medicinal

Antibody structure, instability, and formulation

Wei Wang et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2007)

Add to Collection
Review Biotechnology & Applied Microbiology

Inhaling medicines: delivering drugs to the body through the lungs

John S. Patton et al.

NATURE REVIEWS DRUG DISCOVERY (2007)

Add to Collection
Article Pharmacology & Pharmacy

The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers

YH Liao et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)

Add to Collection
Article Physiology

Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules

C Lombry et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)

Add to Collection
Article Multidisciplinary Sciences

Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway

AJ Bitonti et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Add to Collection
Review Physiology

Protein transport across the lung epithelial barrier

KJ Kim et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)

Add to Collection
Review Pharmacology & Pharmacy

Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications

NR Labiris et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)

Add to Collection
Article Critical Care Medicine

Sex-related differences in cough reflex sensitivity in patients with chronic cough

JA Kastelik et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)

Add to Collection
Article Immunology

Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: Functional expression of FcRn in the mammalian lung

GM Spiekermann et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2002)

Add to Collection
Review Respiratory System

Alveolar epithelial type II cell: defender of the alveolus revisited

H Fehrenbach

RESPIRATORY RESEARCH (2001)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.